Maripat Corr

Title: Maripat Corr: Innovator in Immunotherapy

Introduction

Maripat Corr is a notable inventor based in San Diego, CA. She has made significant contributions to the field of immunotherapy, particularly in the context of head and neck squamous cell carcinomas. With a total of 2 patents, her work focuses on the intricate mechanisms of cancer biology.

Latest Patents

One of her latest patents involves the exploration of Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas. The diverse receptor-ligand pairs of the Wnt and frizzled (Fzd) families play crucial roles during embryonic development and may be overexpressed in cancers arising from immature cells. The study investigated the mRNA levels and expression levels of five Wnt genes (Wnt-1, 5a, 7a, 10b, 13) and two Fzd genes (Fzd-2, 5) in ten head and neck squamous carcinoma cell lines (HNSCC). Additionally, anti-Wnt-1 antibodies were utilized to study the Wnt/Fzd signaling pathway. The results indicate that HNSCC cell lines overexpress one or more Wnt and Fzd genes, suggesting that the proliferation and survival of a subset of HNSCC may depend on the Wnt/Fzd pathway. Therefore, the Wnt and Fzd receptors may serve as valuable targets for immunotherapy of this common cancer.

Career Highlights

Maripat Corr is affiliated with the University of California, where she continues her research and innovation in cancer treatment. Her work has garnered attention for its potential impact on therapeutic strategies for patients suffering from head and neck cancers.

Collaborations

Some of her notable coworkers include Chae-Seo Rhee and Malini Sen, who contribute to the collaborative efforts in advancing research in this critical area of medicine.

Conclusion

Maripat Corr's innovative work in immunotherapy highlights the importance of targeting specific pathways in cancer treatment. Her contributions are paving the way for new therapeutic options for patients with head and neck squamous cell carcinomas.